40 results on '"Mandrup-Poulsen, Thomas"'
Search Results
2. Interleukin-1-receptor antagonist in type 2 diabetes mellitus
3. The Fas pathway is involved in pancreatic [beta] cell secretory function
4. Total mortality by elevated transferrin saturation in patients with diabetes
5. Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes
6. Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation
7. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
8. Proinflammatory cytokines activate the intrinsic apoptotic pathway in β-cells
9. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of β-cell function in therapeutic trials in type 1 diabetes
10. Diabetes and suppressors of cytokine signaling proteins
11. Interleukin-6 and diabetes: the good, the bad, or the indifferent?
12. Is puberty an accelerator of type 1 diabetes in IL6-174CC females?
13. Poor pregnancy outcome in women with type 2 diabetes
14. Cytokines downregulate the sarcoendoplasmic reticulum pump [Ca.sup.2+] ATPase 2b and deplete endoplasmic reticulum [Ca.sup.2+], leading to induction of endoplasmic reticulum stress in pancreatic β-cells
15. Glucose- and interleukin-1[beta]-induced [beta]-cell apoptosis requires [Ca.sup.2+] influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying [K.sup.+] channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets
16. IA-2 antibody-negative status predicts remission and recovery of C-peptide levels in type 1 diabetic patients treated with cyclosporin. (Emerging Treatment and Technologies)
17. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1 beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase
18. Apoptosis and the pathogenesis of IDDM: a question of life and death
19. Diabetes
20. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1beta in vitro and in vivo: association with islet nitric oxide synthesis
21. Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans
22. Two-dimensional gel electrophoresis of rat islet proteins: interleukin 1-beta-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide
23. Glutamic acid decarboxylase (GAD)(sub 65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment
24. Monokine antagonism is reduced in patients with IDDM
25. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans
26. Elevated transferrin saturation and risk of diabetes: three population-based studies
27. Cytokines and type 1 diabetes: a numbers game
28. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients
29. Linkage and association between a CD4 gene polymorphism and IDDM in Danish IDDM patients
30. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study
31. Β-Cell Apoptosis Stimuli and Signaling
32. Islet and stem cell transplantation for treating diabetes
33. Cytokine- or Chemically Derived Nitric Oxide Alters the Expression of Proteins Detected by Two-Dimensional Gel Electrophoresis in Neonatal Rat Islets of Langerhans
34. The c-Jun Amino-Terminal Kinase Pathway Is Preferentially Activated by Interleukin-1 and Controls Apoptosis in Differentiating Pancreatic Β-Cells
35. [Beta]-Cell Maturation Leads to In Vitro Sensitivity to Cytotoxins
36. Testing failures: promising drugs to treat diabetes stumble in the latter stages of clinical testing. Thomas Mandrup-Poulsen explains why--and how to fix it
37. Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans
38. Suppressor of cytokine signaling 3 (SOCS-3) protects [beta]-cells against interleukin-1[beta]-and interferon-[lambda]-mediated toxicity
39. Suppressor of Cytokine Signaling (SOCS)-3 inhibits cytokine-mediated mitogen-activated protein kinase/nuclear factor-[kappa]B activation, nitrogen oxide production, and apoptosis in rat pancreatic [beta]-cells
40. The growth arrest and DNA damage-inducible gene (gadd45[beta]) inhibits proapoptotic Jun N[H.sub.2]-terminal kinase signaling in pancreatic [beta]-cells exposed to interleukin-1[beta]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.